Patients with Crohn's disease who are in remission after treatment with infliximab and immunosuppressives can safely go on to infliximab monotherapy, according to Belgian researchers.
Reuters Health Information
Source: http://www.medscape.com/pharmacists?src=rss
Medscape Pharmacists Headlines